In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity.

In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity.
复制标题

DOI:
10.1038/nbt.3371
复制
发表时间:
2015-11
影响因子:
46.9
通讯作者:
Seder RA
Seder RA
中科院分区:
工程技术1区
文献类型:
--
作者:
Lynn GM;Laga R;Darrah PA;Ishizuka AS;Balaci AJ;Dulcey AE;Pechar M;Pola R;Gerner MY;Yamamoto A;Buechler CR;Quinn KM;Smelkinson MG;Vanek O;Cawood R;Hills T;Vasalatiy O;Kastenmüller K;Francica JR;Stutts L;Tom JK;Ryu KA;Esser-Kahn AP;Etrych T;Fisher KD;Seymour LW;Seder RA

文献摘要

参考文献

被引文献

相似文献

疫苗佐剂如Toll样受体激动剂(TLRa)的功效可以通过配制和递送方法来改善。在这里,我们将小分子TLR-7/8a连接到聚合物支架(聚合物-TLR-7/8a)上,并评估TLR-7/8a和聚合物载体的不同理化性质如何影响体内先天免疫激活的位置、幅度和持续时间。聚合物-TLR-7/8a的颗粒形成对于限制佐剂分布和延长引流淋巴结中的活性至关重要。颗粒聚合物-TLR-7/8a改善的药代动力学特征也与发病率降低和诱导抗体和T细胞免疫的疫苗免疫原性增强相关。我们将这些发现扩展到模块化平台的开发,其中蛋白质抗原与温度响应性聚合物-TLR-7/8a佐剂位点特异性连接,所述温度响应性聚合物-TLR-7/8a佐剂在体内生理温度下自组装成免疫原性颗粒。我们的研究结果提供了一个化学和结构的基础,优化佐剂设计,引发广泛的抗体和T细胞反应的蛋白抗原。
The efficacy of vaccine adjuvants such as Toll-like receptor agonists (TLRa) can be improved through formulation and delivery approaches. Here, we attached small molecule TLR-7/8a to polymer scaffolds (polymer-TLR-7/8a) and evaluated how varying physicochemical properties of the TLR-7/8a and polymer carrier influenced the location, magnitude and duration of innate immune activation in vivo. Particle formation by polymer-TLR-7/8a was critical for restricting adjuvant distribution and prolonging activity in draining lymph nodes. The improved pharmacokinetic profile by particulate polymer-TLR-7/8a was also associated with reduced morbidity and enhanced vaccine immunogenicity for inducing antibodies and T cell immunity. We extended these findings to the development of a modular platform in which protein antigens are site-specifically linked to temperature-responsive polymer-TLR-7/8a adjuvants that self-assemble into immunogenic particles at physiologic temperatures in vivo. Our findings provide a chemical and structural basis for optimizing adjuvant design to elicit broad-based antibody and T cell responses with protein antigens.
DOI: 10.1172/jci45416
发表时间: 2011-05-01
影响因子: 15.9
作者:
Kastenmueller, Kathrin;Wille-Reece, Ulrike;Seder, Robert A.
通讯作者: Seder, Robert A.
DOI: 10.1021/jm049211v
发表时间: 2005-05-19
影响因子: 7.3
作者:
Gerster, JF;Lindstrom, KJ;Lupu, M
通讯作者: Lupu, M
DOI: 10.1073/pnas.1112648109
发表时间: 2012-01-24
影响因子: 11.1
作者:
Moon, James J.;Suh, Heikyung;Irvine, Darrell J.
通讯作者: Irvine, Darrell J.
DOI: 10.1016/j.vaccine.2014.02.027
发表时间: 2014-05-19
期刊: VACCINE
影响因子: 5.5
作者:
Ilyinskii, Petr O.;Roy, Christopher J.;O'Neil, Conlin P.;Browning, Erica A.;Pittet, Lynnelle A.;Altreuter, David H.;Alexis, Frank;Tonti, Elena;Shi, Jinjun;Basto, Pamela A.;Iannacone, Matteo;Radovic-Moreno, Aleksandar F.;Langer, Robert S.;Farokhzad, Omid C.;von Andrian, Ulrich H.;Johnston, Lloyd P. M.;Kishimoto, Takashi Kei
通讯作者: Kishimoto, Takashi Kei
DOI: 10.1073/pnas.1105200108
发表时间: 2011-09-20
影响因子: 11.1
作者:
Jewell, Christopher M.;Lopez, Sandra C. Bustamante;Irvine, Darrell J.
通讯作者: Irvine, Darrell J.